Cure My Disease

Don't miss your cure!

 Log in / Sign up

Can mapping the Blood-Brain barrier in brain tumors unlock new clues?

NCT ID NCT07731555

Recruiting now Knowledge-focused Sponsor: Patrick Morris Source: ClinicalTrials.gov ↗

First seen Jul 28, 2026 · Last updated Jul 29, 2026 · Updated 1 time

Summary

This study aims to characterize blood-brain barrier disruption in people newly diagnosed with glioblastoma, an aggressive brain cancer. Researchers will use advanced MRI scans, blood tests for barrier and nerve injury markers, and analysis of tumor tissue removed during surgery. The goal is to understand how barrier breakdown relates to tumor biology and brain function, which may inform future treatment approaches.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

What this could lead to
If successful, this could lead to better understanding of how the blood-brain barrier breaks down in glioblastoma, potentially guiding future treatments.
What could go wrong
This is an observational study, not a treatment trial, so it won't directly improve outcomes. Results may not translate into clinical changes.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for GLIOBLASTOMA are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

glioblastoma glioma glioma susceptibility 1

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

GLIOBLASTOMA

Contacts and locations

Study contacts

  • Contact

    Email: •••••@•••••

Locations

  • Beaumont RCSI Cancer Centre

    RECRUITING

    Beaumont, D09, Ireland

More trials for these conditions

Other studies related to the condition(s) this trial covers.